P3 Health Partners Inc. — Form 8-K Summary
Report date: November 9, 2023. The filing was made under Item 8.01 (Other Events) and Item 9.01(d) (Exhibits).
Business Context and Reporting Period
P3 Health Partners filed the report to include audited historical financial statements of Foresight Acquisition Corp., its predecessor entity, for incorporation by reference into future Securities Act registration statements.
The statements cover Foresight as of December 2, 2021 and December 31, 2020, and the periods from August 20, 2020 (inception) through December 31, 2020, and from January 1, 2021 through December 2, 2021. P3’s business combinations closed on December 3, 2021, with P3 Health Group Holdings treated as the acquired company for financial reporting purposes under the acquisition method of accounting.
Financial Metrics and Liquidity
This filing does not present current-period revenue, profit, cash flow, margins, debt, liquidity, or operating metrics for P3 Health Partners. The historical Foresight financial statements are attached as Exhibit 99.1, but their detailed figures are not included in the filing text provided.
Material Changes Versus the Prior Comparable Period
No operating or financial-period comparison for P3 Health Partners is disclosed. The principal disclosure is the filing of Foresight’s previously audited financial statements for registration-statement purposes.
Guidance, Outlook, Risks, and Unusual Items
- No management guidance, outlook, new risk factors, contingencies, or unusual operating items are disclosed.
- The filing references the December 3, 2021 business combinations and confirms that the transaction was accounted for as a forward merger, with P3 Health Group Holdings treated as the accounting acquiree.
- Exhibit 23.1 contains the consent of Marcum LLP, Foresight’s former independent registered public accounting firm, for incorporation of the audited financial statements.
Key Facts for Investors to Verify
- Review Exhibit 99.1 for Foresight’s detailed audited balance sheets, statements of operations, cash flows, and related disclosures.
- Confirm how the historical Foresight information is incorporated into future registration statements and distinguish it from P3 Health Partners’ post-business-combination results.
- Review the applicable registration statements, including Forms S-1 filed in November 2022 and May 2023, for the broader transaction and securities disclosures.
- Assess P3’s separate periodic reports for current revenue, losses, cash burn, debt, liquidity, and forward-looking guidance, none of which are provided in this 8-K.